US EditionPublished • loading... • Updated
Annovis Sets Investor Webinar as Neurodegeneration Pipeline Reaches Inflection
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Annovis Sets Investor Webinar as Neurodegeneration Pipeline Reaches Inflection
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) said it will host a corporate update webinar later this month as the clinical-stage biotechnology company moves into what it describes as a milestone-rich period for its neurological disease programs. The webinar is scheduled for Wednesday, January 28, 2026, at 4:30 p.m. Eastern and will be led by President and Chief Executive Officer Maria Maccecchini. The presentation will outline recent company pro…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
